Motif Biotech provides high-purity peptide products and custom synthesis services for metabolic, immune, and tissue repair research. Our core portfolio includes advanced process development for molecules such as Semaglutide, Tirzepatide, and next-gen multi-target agonists like UBT251 and Retatrutide. We excel in complex side-chain modifications and rigorous impurity profiling to ensure CMC compliance. Our products and services primarily serve global biopharma innovators, research institutes, and generic developers. These solutions are widely applied in drug discovery and manufacturing for diabetes, obesity, MASH (NASH), and autoimmune diseases. We support clients with global clinical filings by providing one-stop peptide solutions that meet stringent international quality standards.
